SCHEMBL15470845

SCHEMBL15470845

COCCCCCCCCCCCCOc1ccc2c(c1)C(Br)(c1cccc(F)c1)c1ccccc1-2

nearest known ligand 0.46

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 20/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31193446 0.91 PDK2 (0.56) PDK2
SCHEMBL538517 0.89 PDK2 (0.53) PDK2
SCHEMBL21464021 0.86 PDK2 (0.52) PDK2
SCHEMBL15470849 0.84 PDK2 (0.45) PDK2
SCHEMBL31003499 0.77 PDK2 (0.42) PDK2
SCHEMBL28501701 0.75 PDK2 (0.42) PDK2
SCHEMBL10251466 0.74 PDK2 (0.54) PDK2
SCHEMBL15608159 0.74 PDK2 (0.59) PDK2
SCHEMBL538516 0.73 PDK2 (0.56) PDK2
SCHEMBL20436810 0.73 PDK2 (0.51) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9029504-B2 Fluorene compound AJINOMOTO CO., INC. (JP) 2015-05-12 US disclosed
US-20140046022-A1 FLUORENE COMPOUND AJINOMOTO CO., INC. (JP) 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140046022-A1 FLUORENE COMPOUND NPPA, FURIN, SFPQ PDK2 3174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.